127 related articles for article (PubMed ID: 9753648)
1. Reconstitution of IL6-inducible differentiation of a myeloid leukemia cell line by activated Stat factors.
Piekorz R; Schlierf B; Burger R; Hocke GM
Biochem Biophys Res Commun; 1998 Sep; 250(2):436-43. PubMed ID: 9753648
[TBL] [Abstract][Full Text] [Related]
2. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
Piekorz RP; Hocke GM
Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
[TBL] [Abstract][Full Text] [Related]
3. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998
[TBL] [Abstract][Full Text] [Related]
4. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
[TBL] [Abstract][Full Text] [Related]
5. Differential binding activity of the transcription factor LIL-STAT in immature and differentiated normal and leukemic myeloid cells.
Tuyt LM; Bregman K; Lummen C; Dokter WH; Vellenga E
Blood; 1998 Aug; 92(4):1364-73. PubMed ID: 9694725
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
8. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
Bellido T; Borba VZ; Roberson P; Manolagas SC
Endocrinology; 1997 Sep; 138(9):3666-76. PubMed ID: 9275051
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the activation status of Stat5a during LIF-induced differentiation of M1 myeloid leukemia cells.
Piekorz RP; Rinke R; Gouilleux F; Neumann B; Groner B; Hocke GM
Biochim Biophys Acta; 1998 Apr; 1402(3):313-23. PubMed ID: 9606990
[TBL] [Abstract][Full Text] [Related]
10. Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells.
Tanuma N; Nakamura K; Shima H; Kikuchi K
J Biol Chem; 2000 Sep; 275(36):28216-21. PubMed ID: 10859312
[TBL] [Abstract][Full Text] [Related]
11. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
12. The role of STATs in myeloid differentiation and leukemia.
Coffer PJ; Koenderman L; de Groot RP
Oncogene; 2000 May; 19(21):2511-22. PubMed ID: 10851050
[TBL] [Abstract][Full Text] [Related]
13. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases.
Sengupta TK; Talbot ES; Scherle PA; Ivashkiv LB
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11107-12. PubMed ID: 9736697
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli.
Hosui A; Ohkawa K; Ishida H; Sato A; Nakanishi F; Ueda K; Takehara T; Kasahara A; Sasaki Y; Hori M; Hayashi N
J Biol Chem; 2003 Aug; 278(31):28562-71. PubMed ID: 12764155
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.
Weber-Nordt RM; Egen C; Wehinger J; Ludwig W; Gouilleux-Gruart V; Mertelsmann R; Finke J
Blood; 1996 Aug; 88(3):809-16. PubMed ID: 8704235
[TBL] [Abstract][Full Text] [Related]
16. STAT3 exerts two-way regulation in the biological effects of IL-6 in M1 leukemia cells.
Zhang J; Shen B; Li Y; Sun Y
Leuk Res; 2001 Jun; 25(6):463-72. PubMed ID: 11337018
[TBL] [Abstract][Full Text] [Related]
17. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
18. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.
Nakajima K; Yamanaka Y; Nakae K; Kojima H; Ichiba M; Kiuchi N; Kitaoka T; Fukada T; Hibi M; Hirano T
EMBO J; 1996 Jul; 15(14):3651-8. PubMed ID: 8670868
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Stat3 signaling pathway is required for differentiation by interleukin-6 in PC12-E2 cells.
Wu YY; Bradshaw RA
J Biol Chem; 2000 Jan; 275(3):2147-56. PubMed ID: 10636920
[TBL] [Abstract][Full Text] [Related]
20. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
Quentmeier H; Zaborski M; Drexler HG
Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]